Abbott Laboratories (ABT) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Abbott Laboratories, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Abbott Laboratories (ABT) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $178.4B. It trades at $102.64, down 0.45% today, at 38 times earnings. Its overall quality score is 45 out of 100, ranked against the whole US market. 17 analysts' average target of $121.94 implies +18.8% from today's price. Kronos AI's 30-day forecast is −1.2% (3 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $121.94 |
| Low – high | $115.00 – $135.00 |
| Analysts | 17 |
| Upside to average | +18.8% |
Kronos AI 30-day forecast
| Expected close | $101.84 (−1.2%) |
| Likely range | −2.8% … +1.1% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 50 |
| Solvency | 37 |
| Growth | 48 |
| Overall | 45 |
| P/E | 38 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator